If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before de ...

A recent study conducted by researchers from Seattle-based University of Washington and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs and ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...